在儿童中治疗SARS-CoV-2感染的治疗方法
1Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Journal of clinical medicine
|January 11, 2024
概括
本综述综合了治疗儿科SARS-CoV-2 (COVID-19) 感染的专家指南. 它涵盖了早期的抗病毒疗法和以后的免疫失调治疗,包括儿童多系统炎症综合征 (MIS-C).
科学领域:
- 儿童传染病 儿童传染病
- 病毒学 病毒学
- 临床治疗学 临床治疗学
背景情况:
- SARS-CoV-2 (COVID-19) 对儿童的影响通常不如成人严重,但高风险群体面临严重后果.
- 有限的儿科临床试验需要推断成人的数据,以确定儿童的治疗疗效.
- 专家共识指南由NIH,IDSA和PIDS开发,以解决儿科COVID-19治疗问题.
研究的目的:
- 综合针对儿童SARS-CoV-2感染的治疗管理的综合建议.
- 为儿童COVID-19治疗早期感染期和晚期免疫失调的治疗提供指导.
- 概述儿童多系统炎症综合征 (MIS-C) 的治疗方法.
主要方法:
- 审查和综合来自国家卫生和传染病学会的专家共识指南.
- 对早期SARS-CoV-2感染和后来的免疫并发症的治疗策略的分析.
- 包括抗病毒药物,皮质类固醇和免疫调节剂的治疗方案.
主要成果:
- 这些建议涵盖了早期的抗病毒治疗,包括使用remdesivir和nirmatrelvir/ritonavir等药物.
- 该指南针对使用皮质类固醇和免疫调节剂的晚期免疫失调.
- 详细介绍了儿童多系统炎症综合征 (MIS-C) 的具体治疗方法.
结论:
- 对于儿科SARS-CoV-2治疗,存在全面的指导方针,解决各种疾病阶段和并发症.
- 治疗策略利用基于专家共识的抗病毒和免疫调节方法.
- 管理MIS-C是儿科COVID-19治疗建议的关键组成部分.
相关概念视频
Pneumonia IV: Management
331
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
331
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Acute Respiratory Failure-V
141
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
141


